Tofacitinib Ointment For Atopic Dermatitis (Atopic Eczema)
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The study is being conducted to evaluate the efficacy, safety and tolerability of 2%
tofacitinib ointment (20 mg/g) BID (twice daily) in subjects with mild to moderate atopic
dermatitis compared to placebo (vehicle) BID for 4 weeks.